Partnerships
Collaborative R&D
Licensing
■ Collaborative R&D
MBRI actively seeks experienced partners to advance the development and commercialization of
our own product candidates
. Several important candidates in our pipeline are as follows.
•
Multivalent prophylactic vaccine for HCV and HBV infection.pdf
•
Therapeutic application of siRNAs for hepatic viral diseases.pdf
•
T cell-targeted drugs for treatment of rheumatoid arthritis.pdf
•
Recombinant human parathyroid hormone.pdf
•
Greenstatin™, an anti-angiogenic and anti-cancer agent.pdf
Download Adobe Reader ☞
Copyright© 2004 MOGAM Biotechnology Research Institute. All Rights Reserved.
